What is LOPJLB’s current signal on ONCO?

LOPJLB’s latest quantitative signal on Onconetix, Inc. (ONCO) is SELL in a CRISIS regime. Signals are updated daily.

What market regime is ONCO in?

Onconetix, Inc. (ONCO) is currently classified in the CRISIS HMM market regime on LOPJLB.

What does Onconetix, Inc. (ONCO) do?

Onconetix, Inc. operates as a biotechnology and pharmaceutical firm, committed to pioneering and bringing to market innovative treatments aimed at resolving critical health issues worldwide. The company's product lineup includes Entadfi, an FDA-cleared, once-daily oral medication. This prescription drug combines finasteride and tadalafil to manage benign prostatic hyperplasia (BPH). In its deve…

Where is Onconetix, Inc. based / listed?

Onconetix, Inc. is based in US, listed on NASDAQ.

Onconetix, Inc. (ONCO)

COMPARE

Healthcare · Biotechnology · NASDAQ · US

$0.65+8.33%Close

SELLCRISIS · day 7

RANGE

LOPJLB.COM

OHLCEMALEVELSSTOPFLIP52WSIGNALSBUYSELLEXHEXH ZONE

Key stats

Short interest · FINRA settlement 2026-09-15

Market cap: $217,119
Beta: 2.67
P/E (TTM): -0.08

Short % float: 96.23%
Days to cover: 1.0
SI change: -19.6%

1W: -12.16%
1M: -19.75%

vs SPY 1W: -13.72%
vs SPY 1M: -21.52%

Prediction markets

Kalshi · Polymarket · … linked

Full prediction markets →

Loading markets…

Key stats

Prediction markets

Company news